These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18273574)

  • 1. [Antithrombotic therapy in congestive heart failure].
    Adam O; Böhm M
    Herz; 2008 Feb; 33(1):20-4. PubMed ID: 18273574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral anticoagulation in patients with cardiomyopathy or heart failure in sinus rhythm.
    Pullicino P; Thompson JL; Mohr JP; Sacco RL; Freudenberger R; Levin B; Homma S
    Cerebrovasc Dis; 2008; 26(3):322-7. PubMed ID: 18667814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolism and antithrombotic therapy in congestive heart failure.
    Dunkman WB
    J Cardiovasc Risk; 1995 Apr; 2(2):107-17. PubMed ID: 7606647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for antithrombotic therapy in atrial fibrillation.
    Kelley RE
    Neurol Clin; 1992 Feb; 10(1):233-49. PubMed ID: 1557005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic therapy for congestive heart failure.
    Chung I; Lip GY
    Int J Clin Pract; 2006 Jan; 60(1):36-47. PubMed ID: 16409427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-centre experience.
    Halbfass P; Janko S; Dorwarth U; Riess G; Antoni D; Hoffmann E
    Europace; 2009 Jul; 11(7):957-60. PubMed ID: 19493910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation in patients with atrial fibrillation and congestive heart failure.
    Veloso HH; de Paola AA
    Am J Cardiol; 2005 Jun; 95(12):1533. PubMed ID: 15950594
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy.
    Kronborg MB; Albertsen AE; Nielsen JC; Mortensen PT
    Europace; 2009 Sep; 11(9):1177-82. PubMed ID: 19661114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulation in chronic heart failure and left ventricular dysfunction].
    Wichter T; Breithardt G
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?
    Katz SD
    J Cardiovasc Risk; 1995 Apr; 2(2):97-102. PubMed ID: 7606657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study.
    Anselmino M; De Ferrari GM; Massa R; Manca L; Tritto M; Molon G; Curnis A; Devecchi P; Sarzi Braga S; Bartesaghi G; Klersy C; Accardi F; Salerno-Uriarte JA;
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S214-8. PubMed ID: 19250099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting the most out of life.
    Schwartzman D
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1167-8. PubMed ID: 18631267
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticoagulant treatment and cardiac insufficiency].
    Bounhoure JP; Galinier M; Pathak A
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():29-32. PubMed ID: 10830086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.